News
3P Biopharmaceuticals increases its microbial production capacity with the installation of a 500 L fermenter.
Published: 1st March 2023
The fermenter adds to 3P's capacity for manufacturing biological medicinal products using microbial technology.
Read more
3P Biopharmaceuticals has a 68% female workforce with a scientific background.
Published: 10th February 2023
On the occasion of the International Day of Women and Girls in Science, the company presents 5 stories of science in feminine.
Read more
3P Biopharmaceuticals among the 500 fastest growing companies in Spain
Published: 19th December 2022
This is the first year the company appears in the ranking established by CEPYME for 500 companies that lead business growth in Spain.
Read more
3P Biopharmaceuticals brings together leading international experts in biomedicine to celebrate its 15th anniversary.
Published: 1st December 2022
The event gathered an audience of more than 150 people and was attended by Juan Cruz Cigudosa, Councillor for University, Innovation, and Digital Transformation.
Read more
BrainEver and 3P Biopharmaceuticals collaborate on development of recombinant human homeoprotein Engrailed-1
Published: 15th November 2022
3P Bio will focus on the transfer of the production process as well as the cGMP manufacturing of the drug substance to be used in Phase I and II clinical trials. The novel drug could cure neurodegenerative diseases such as Amyotrophic Lateral Sclerosis.
Read more
3P Biopharmaceuticals awards the prize for the best Master’s Thesis (TFM)
Published: 3rd October 2022
At the closing of the fifth edition of the Master in Galenic Design and Manufacturing in the Pharmaceutical Industry of the University of Navarra.
Read more
3P Biopharmaceuticals among the 100 best companies to work for in Spain
Published: 27th September 2022
The prestigious ranking is based on an exhaustive questionnaire that Actualidad Económica prepares and publishes every year, and which seeks to evaluate and reward those companies whose human resources management makes them benchmarks.
Read more
3P Biopharmaceuticals celebrates its 15th anniversary with Juan Carlos Unzué.
Published: 29th July 2022
3P Biopharmaceuticals, a Navarre company founded in 2007, met with 370 employees in an exciting and joyful event looking back over its 15 years of trajectory.
Read more
3P Biopharmaceuticals and Biosergen complete together the manufacture of biomass for the Mucormycosis “Black Fungus” clinical phase II trial.
Published: 11th July 2022
3P Biopharmaceuticals has completed the manufacture of BSG005 biomass planned for its client Biosergen. The client also recently announced Phase II clinical trial of BSG005 against Mucormycosis, otherwise known as the Black Fungus.
Read more